Human mesenchymal stem cells derived from bone marrow display a better chondrogenic differentiation compared with other sources.
about
Stem cells and cell therapies in lung biology and lung diseasesMesenchymal stromal cell therapy is associated with increased adenovirus-associated but not cytomegalovirus-associated mortality in children with severe acute graft-versus-host disease.Horse bone marrow mesenchymal stem cells express embryo stem cell markers and show the ability for tenogenic differentiation by in vitro exposure to BMP-12.Human mesenchymal stem cells: a bank perspective on the isolation, characterization and potential of alternative sources for the regeneration of musculoskeletal tissues.Stemness evaluation of mesenchymal stem cells from placentas according to developmental stage: comparison to those from adult bone marrowCD106 identifies a subpopulation of mesenchymal stem cells with unique immunomodulatory properties.Modification of histone acetylation facilitates hepatic differentiation of human bone marrow mesenchymal stem cells.IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma.Cartilage matrix formation by bovine mesenchymal stem cells in three-dimensional culture is age-dependentMesenchymal stromal cells of osteosarcoma patients do not show evidence of neoplastic changes during long-term culture.Current View on Osteogenic Differentiation Potential of Mesenchymal Stromal Cells Derived from Placental Tissues.Fetal mesenchymal stromal cells differentiating towards chondrocytes acquire a gene expression profile resembling human growth plate cartilageTranscriptomic comparison of osteopontin, osteocalcin and core binding factor 1 genes between human adipose derived differentiated osteoblasts and native osteoblastsGreat promise of tissue-resident adult stem/progenitor cells in transplantation and cancer therapiesRecent progress on tissue-resident adult stem cell biology and their therapeutic implications.Cells and biomaterials in cartilage tissue engineering.Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways.Cell surface proteomics analysis indicates a neural lineage bias of rat bone marrow mesenchymal stromal cells.Human fetal and adult bone marrow-derived mesenchymal stem cells use different signaling pathways for the initiation of chondrogenesis.Mesenchymal Stem and Progenitor Cells in Regeneration: Tissue Specificity and Regenerative Potential.Mesenchymal stem cell differentiation and roles in regenerative medicine.Mesenchymal stromal cell therapy: a revolution in Regenerative Medicine?Phenotypic and functional heterogeneity of human bone marrow- and amnion-derived MSC subsets.Malignant fibrous histiocytoma and fibrosarcoma of bone: a re-assessment in the light of currently employed morphological, immunohistochemical and molecular approaches.The clinical use of bone morphogenetic proteins revisited: a novel biocompatible carrier device OSTEOGROW for bone healing.The challenge of pancreatic cancer therapy and novel treatment strategy using engineered mesenchymal stem cells.Application of human bone marrow-derived mesenchymal stem cells in the treatment of radiation-induced Gastrointestinal syndrome.Effects of initial cell seeding in self assembly of articular cartilage.Mesenchymal Stem/Progenitor Cells Derived from Articular Cartilage, Synovial Membrane and Synovial Fluid for Cartilage Regeneration: Current Status and Future Perspectives.Remestemcel-L for the treatment of graft versus host disease.Role of Mesenchymal Stem Cells in Cancer Development and Their Use in Cancer Therapy.Induction of pluripotency in adult equine fibroblasts without c-MYC.Xeno-free chondrogenesis of bone marrow mesenchymal stromal cells: towards clinical-grade chondrocyte production.Comparative study of equine bone marrow and adipose tissue-derived mesenchymal stromal cells.Induction of hepatic differentiation of mouse bone marrow stromal stem cells by the histone deacetylase inhibitor VPA.Enzymatic characterization of novel arylsulfatase A variants using human arylsulfatase A-deficient immortalized mesenchymal stromal cells.Comparison of fibrin clots derived from peripheral blood and bone marrow.Stem Cells for Cartilage Repair: Preclinical Studies and Insights in Translational Animal Models and Outcome Measures.Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study.Comparison of alternative mesenchymal stem cell sources for cell banking and musculoskeletal advanced therapies
P2860
Q30486086-8F0A12A4-0316-4DB4-A3F6-939BFF973949Q30585387-E23D1BE1-034C-49E7-BE2F-1FD7B0D9DF4DQ33433291-76FE0F5C-A21D-4A00-82A2-364486D90994Q33455061-8ABA4B6C-BF16-4DB5-A07C-576F6601E092Q34159690-A7208858-6CC1-4516-B64B-6CDF5E421AC5Q34649030-38BDFE29-BEE4-42F5-A6B6-9431F2315792Q34713160-4E8E2338-C9F3-4680-921F-8352F65C9406Q34728942-A7A5C49B-B6AF-41D4-8D06-9B90CDC4168FQ35209357-F354241A-0576-422B-9C70-24706E09AA39Q35770479-253C5D0D-C1E1-4A01-A98A-877FF101A19EQ35825031-09231030-3210-4901-93AE-6575FC63E5B3Q36373757-383E562F-5C11-4F64-9D63-AAEA2617816FQ36425110-C5488287-78A2-4FD6-B386-7C613258041BQ36819400-2DA1DEF3-EC14-43D2-BF44-CBD789F00924Q37089825-EDEE68BC-7C0A-4AED-BEF4-6DEBCC8A3096Q37357270-8E3D8335-44A7-4AC9-A91A-6438D678AF05Q37457708-534B41BC-3422-4324-895F-F24416BEBE19Q37556618-27765612-85D7-4BD1-81F6-A40E685A90A1Q37593395-0F41C553-DD56-45C8-BB95-1A49BA5D2D5AQ37668908-D7B20C93-ACBE-4496-B342-CC516BF0CE9EQ37787932-C02FD158-854E-4EE7-B1D1-68778027ED3CQ37863460-9D8AE2D4-D331-4F7B-9F82-4B8F1144DA6FQ38035445-A6DF769E-FA17-498D-9D2F-95CDBB493A41Q38045777-8BF68210-59BE-453E-B95A-6C17843675F8Q38172438-58823CB1-EC67-4738-90D9-60AAF15E1F8EQ38175297-32152560-98A0-48EE-91D0-21F4FFFBC171Q38247859-ACEACA52-83CD-403A-9DB7-8E49A4E74BDAQ38274946-04C2CD3C-A34E-4F41-9941-38CDF2522586Q38655477-011EE6E6-090D-4B18-A296-B731D48AF885Q38892351-F7B83962-AB98-475F-825B-7E227E1FB9FBQ39449623-3B761155-02D3-4102-A952-7BB59D3717B6Q42144028-88C44ABF-F8D3-40FA-AC1F-BF0A22E6F479Q42577722-657C3611-23C4-4E1A-975A-E3F941F8430DQ45935185-7D9DFE62-2450-4F91-B1A2-FCFFC305F4BBQ46427710-DE4CF5C6-37B0-4B21-82EF-1AB1E08F9BA6Q48171284-C8524352-0501-4781-A13B-AA32CE6A5B22Q49155236-AF868AC5-BAA4-4444-AD46-37C9143522F7Q51734158-60AEEDAB-28DE-4BF7-992E-E1DB24DE5E90Q51852822-9B11CAD6-7D2F-4262-921C-0653AA614FCBQ56985934-E1CAEA3E-F724-421A-96C9-392DA802A6A2
P2860
Human mesenchymal stem cells derived from bone marrow display a better chondrogenic differentiation compared with other sources.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Human mesenchymal stem cells d ...... n compared with other sources.
@en
Human mesenchymal stem cells d ...... n compared with other sources.
@nl
type
label
Human mesenchymal stem cells d ...... n compared with other sources.
@en
Human mesenchymal stem cells d ...... n compared with other sources.
@nl
prefLabel
Human mesenchymal stem cells d ...... n compared with other sources.
@en
Human mesenchymal stem cells d ...... n compared with other sources.
@nl
P2093
P2860
P1476
Human mesenchymal stem cells d ...... n compared with other sources.
@en
P2093
Bernardo ME
Karperien M
Locatelli F
Rappold GA
Vukicevic S
P2860
P304
P356
10.1080/03008200701228464
P577
2007-01-01T00:00:00Z